News Headlines Article

Few options to curb specialty-drug costs: study
Modern Healthcare

There are few options to control increasing spending on high-cost specialty drugs, which raises questions for the insurers, employers and patients grappling with growing usage of specialty drugs, according to a study from the Center for Studying Health System Change.

Specialty drugs are typically biologics developed to treat complex medical conditions such as rheumatoid arthritis, multiple sclerosis or cancer.